Results 51 to 60 of about 88,400 (300)

Macrolide Resistance in Mycoplasma pneumoniae, Israel, 2010

open access: yes, 2011
Macrolide resistance in Mycoplasma pneumoniae is often found in Asia but is rare elsewhere. We report the emergence of macrolide-resistant M. pneumoniae in Israel and the in vivo evolution of such resistance during the treatment of a 6-year-old boy with ...
Dan Engelhard   +4 more
core   +1 more source

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease

open access: yesBMC Pulmonary Medicine, 2019
Background A three-drug regimen (macrolide, ethambutol, and rifampicin) is recommended for the treatment of Mycobacterium avium complex pulmonary disease (MAC-PD).
Hyung-Jun Kim   +6 more
doaj   +1 more source

Bacteriological and Molecular Identification of some Campylobacter Species in Broilers and their Macrolide Resistance Profile [PDF]

open access: yesBenha Veterinary Medical Journal, 2018
Genus campylobacter including several species is of great importance that is considered among the major causative agents of acute diarrheal diseases in humans worldwide.
Ahmed Hefny   +3 more
doaj   +1 more source

Detection of macrolide and fluoroquinolone resistance-associated 23S rRNA and parC mutations in Mycoplasma genitalium by nested real-time PCR

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
BackgroundTraditional drug susceptibility testing cannot be performed in clinical laboratories due to the slow-growing characteristics of Mycoplasma genitalium when cultured in vitro. Sanger sequencing is the standard method for detecting drug resistance-
Wenyin He   +5 more
doaj   +1 more source

Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia

open access: yesMolecular Therapy: Nucleic Acids
Splicing factor 3b subunit 1 (SF3B1) is the largest subunit and core component of the spliceosome. Inhibition of SF3B1 was associated with an increase in broad intron retention (IR) on most transcripts, suggesting that IR can be used as a marker of ...
Manoj Kumar Kashyap   +19 more
doaj   +1 more source

Macrolides: The Plug Is Out [PDF]

open access: yesCell, 2012
Macrolide antibiotics are thought to clog up the ribosomal tunnel and thereby block general protein synthesis. By using a combination of elegant in vivo and in vitro approaches, Kannan et al. show that the inhibitory action of these drugs on bacterial protein synthesis is selective rather than global.
Gamerdinger, Martin, Deuerling, Elke
openaire   +3 more sources

Antimicrobial drug use and macrolide-resistant **Streptococcus pyogenes**, Belgium

open access: yes, 2012
: In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 19972007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 19992009.
Samuel Coenen   +11 more
core   +1 more source

Macrolide resistance determinants among isolates from carriers in Central Greece [PDF]

open access: yes, 2012
Background: We sought to characterize the temporal trends in nasopharyngeal carriage of macrolide-resistant pneumococci during a period with increased heptavalent pneumococcal conjugate vaccine (PCV7) coverage in Central Greece.
Grivea, I. N.   +11 more
core   +2 more sources

Detection of pbp2b and ermB genes in clinical isolates of Streptococcus pneumoniae

open access: yesJournal of Infection in Developing Countries, 2008
Background: Streptococcus pneumoniae is a major human pathogen. The emergence of penicillin resistant strains since the 1970s has been life threatening and the evolution of the bacteria have enabled itself to develop resistance to many other antibiotics ...
Navindra Kumari   +2 more
doaj   +1 more source

Imidazoquinolines with improved pharmacokinetic properties induce a high IFNα to TNFα ratio in vitro and in vivo

open access: yesFrontiers in Immunology, 2023
TLR Agonists have promising activity in preclinical models of viral infection and cancer. However, clinical use is only in topical application. Systemic uses of TLR-ligands such as Resiquimod, have failed due to adverse effects that limited dose and thus,
Manuel Keppler   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy